Acute Liver Failure Associated with Levetiracetam and Lacosamide Combination Treatment for Unspecified Epileptic Disorder

Background and Aim. Levetiracetam is a second-generation antiepileptic drug. It is approved as an adjunctive treatment of partial onset seizures with or without secondary generalization. It is considered safe with less than 1% of patients with transient elevations of liver enzymes. Methods. We repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez-Grobe, Ylse, Bahena-Gonzalez, Jose Antonio, Herrera-Gomar, Magali, Mendoza-Diaz, Pedro, García-López, Sandra, González-Chon, Octavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762071/
https://www.ncbi.nlm.nih.gov/pubmed/24027645
http://dx.doi.org/10.1155/2013/634174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762071/
https://www.ncbi.nlm.nih.gov/pubmed/24027645
http://dx.doi.org/10.1155/2013/634174

Ejemplares similares